1026 related articles for article (PubMed ID: 23720182)
1. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary arterial hypertension in congenital heart defects with shunt: a heterogeneous and complex constellation].
Zimmermann R; Schranz D; Ewert P; Kaemmerer H
Dtsch Med Wochenschr; 2013 Jun; 138(23):1244-6. PubMed ID: 23720181
[TBL] [Abstract][Full Text] [Related]
3. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
4. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Sompradikul S
J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
[TBL] [Abstract][Full Text] [Related]
6. A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease.
Strange G; Rose M; Kermeen F; O'Donnell C; Keogh A; Kotlyar E; Grigg L; Bullock A; Disney P; Dwyer N; Whitford H; Tanous D; Frampton C; Weintraub R; Celermajer DS
Intern Med J; 2015 Sep; 45(9):944-50. PubMed ID: 26011062
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions.
Gatzoulis MA; Beghetti M; Landzberg MJ; Galiè N
Int J Cardiol; 2014 Dec; 177(2):340-7. PubMed ID: 25443244
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21.
Kermeen FD; Franks C; O'Brien K; Seale H; Hall K; McNeil K; Radford D
Heart Lung Circ; 2010 Oct; 19(10):595-600. PubMed ID: 20728407
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
Duffels M; van Loon L; Berger R; Boonstra A; Vonk-Noordegraaf A; Mulder B
Congenit Heart Dis; 2007; 2(4):242-9. PubMed ID: 18377475
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Kozlik-Feldmann R; Hansmann G; Bonnet D; Schranz D; Apitz C; Michel-Behnke I
Heart; 2016 May; 102 Suppl 2():ii42-8. PubMed ID: 27053697
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
[TBL] [Abstract][Full Text] [Related]
13. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
14. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
Monfredi O; Griffiths L; Clarke B; Mahadevan VS
Am J Cardiol; 2011 Nov; 108(10):1483-8. PubMed ID: 21943933
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry.
Alonso-Gonzalez R; Lopez-Guarch CJ; Subirana-Domenech MT; Ruíz JMO; González IO; Cubero JS; Del Cerro MJ; Salvador ML; Subira LD; Gallego P; Escribano-Subias P;
Int J Cardiol; 2015 Apr; 184():717-723. PubMed ID: 25781723
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease.
Gatzoulis MA; Alonso-Gonzalez R; Beghetti M
Eur Respir Rev; 2009 Sep; 18(113):154-61. PubMed ID: 20956136
[TBL] [Abstract][Full Text] [Related]
19. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
van Loon RL; Roofthooft MT; Hillege HL; ten Harkel AD; van Osch-Gevers M; Delhaas T; Kapusta L; Strengers JL; Rammeloo L; Clur SA; Mulder BJ; Berger RM
Circulation; 2011 Oct; 124(16):1755-64. PubMed ID: 21947294
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
